Balanced news tone
News Sentiment
MARKSANS sentiment intelligence
Marksans Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
+3.0% over one week, +7.9% over four weeks, trend active, and materially above fair value.
Marksans Pharma to acquire German firm ABCnow GmbH for €892,384
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Marksans Pharma Full Year 2025 Earnings: In Line With Expectations
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jul 2025 07:00
- Source
- simplywall.st
Stocks to buy today: CCL Products, Marksans Pharma; check target, stop-loss
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 07 Jul 2025 07:00
- Source
- Business Standard
Here's why Marksans Pharma share price increased over 2% in trade on May 15
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2025 07:00
- Source
- Business Standard
Pharma stocks that you can keep in your portfolio despite US tariff woes
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 03 Apr 2025 07:00
- Source
- Business Standard
Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Mar 2025 07:00
- Source
- Business Standard
What drew MIT's investment arm to this small cap pharma company?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2024 07:00
- Source
- Moneycontrol.com